Clinical Trial Update: BTX-A Treatment for Palmar Hyperhidrosis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports results for botulinum toxin type A (BTX-A) in treating palmar hyperhidrosis, spanning Phase 2 and Phase 3, with the study ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Hyperhidrosis of the Hands

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Primary Focal Hyperhidrosis of the Hands | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2015-01-26